KMB
Kimberly-Clark Corporation
October 15, 2026 · pre-market
- Rarity
- 1.54
- Peak move
- +5.14%
- Float cap
- $32.9B
Kimberly-Clark Corporation makes personal care and tissue products under brands including Huggies, Kleenex, Scott, Kotex, Poise, and Depend. Its consumer products are sold to supermarkets, mass merchandisers, drugstores, and other retailers, while professional items are distributed to businesses and facilities. The company operates in more than 175 countries and holds No. 1 or No. 2 positions in about 70 markets.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
7 events · 0 from SEC or newswire · 1 timed with the move- Timed with the move
preannouncementKimberly-Clark released preliminary third-quarter 2026 financial data ahead of its scheduled November 5 report, with net sales of $4.13 billion and adjusted EPS of $1.70, and reaffirmed its full-year 2026 outlook of organic sales growth about 100 bps below weighted average category growth, constant-currency adjusted operating profit up mid-single digits and adjusted EPS down low single digits, citing China social media disruptions.
analyst_ratingCitigroup maintained a Sell rating on Kimberly-Clark with a $90 price target.
analyst_ratingTD Cowen lowered its price target on Kimberly-Clark to $97 from $104 while maintaining a Hold rating.
notable_investor_commentJim Cramer's Charitable Trust bought 85 Kimberly-Clark shares at roughly $97 each, raising its position to 600 shares and portfolio weighting to about 1.5%, citing the approaching Kenvue acquisition and EU approval.
regulatory_approvalThe European Commission conditionally approved Kimberly-Clark's roughly $40-49 billion acquisition of Kenvue, requiring Kimberly-Clark to divest all its EEA tampon and feminine hygiene brands — Kotex (including Lidie), Camelia and Record — to Turkey's Dilek Grup.
debt_financingKimberly-Clark said it received the requisite consents to amend terms of outstanding Kenvue Inc. notes and amended the terms of its exchange offers for those notes, announcing early tender results for exchange offers of up to $7.0 billion of new Kimberly-Clark notes plus cash for outstanding Kenvue notes, with settlement expected no earlier than Nov 2, 2026.
spinoff_divestitureTo satisfy EU antitrust concerns, Kimberly-Clark committed to sell its EEA feminine hygiene brands Kotex (including Lidie), Camelia and Record, including IP, know-how and key employees, to Turkish consumer-goods distributor Dilek Grup, which the Commission separately approved as buyer.